Economy/Home · Economy

Aprogen to Issue 20 Billion Won in Convertible Bonds to Acquire Aprogen Biologics Securities

Aprogen will issue 20 billion won worth of convertible bonds to raise funds for the acquisition of Aprogen Biologics securities. According to a regulatory filing on the 3rd, Aprogen decided to issue its 35th series of unregistered, warrant-attached, unguaranteed privately placed convertible bonds i

Oseong Kwon
Staff Reporter
4 min read
Aprogen to Issue 20 Billion Won in Convertible Bonds to Acquire Aprogen Biologics Securities
CBC News

Aprogen will issue 20 billion won worth of convertible bonds to raise funds for the acquisition of Aprogen Biologics securities.

According to a regulatory filing on the 3rd, Aprogen decided to issue its 35th series of unregistered, warrant-attached, unguaranteed privately placed convertible bonds in order to raise funds to acquire securities of another corporation. The total face value is 20 billion won, and all of the raised funds will be used to acquire Aprogen Biologics securities. According to the filing, Aprogen Biologics' business is the manufacturing and sale of pharmaceuticals and other products.

Issuance Terms

The coupon interest rate is 0%, and the maturity interest rate is 4%. The maturity date is September 11, 2031, and if held until maturity, the bonds will be repaid in a lump sum at 122.0190% of the electronically registered amount.

The conversion price is 2,396 won per share, and upon conversion, 8,347,245 registered common shares of Aprogen will be issued. This represents 24.55% of the total number of shares stated in the filing. The conversion request period runs from September 12, 2027 to August 11, 2031. The minimum adjusted conversion price in the event of a decline in market price is 1,678 won.

Subscribers and Schedule

All subscribers are affiliates of the company: Entuck with 10 billion won, Aptocrom with 7 billion won, and Aprogen Pharma with 3 billion won. The subscription date is September 3, 2026, and the payment date is the 11th of the same month. Payment will be made in cash.

Early Redemption Option (Put Option)

Bondholders may exercise the early redemption option (put option) every three months beginning on September 11, 2028, two years after the issuance date. The early redemption rate on the first early redemption date is 108.2856%.

Convertible Bond Balance After Issuance

As of the filing, Aprogen's outstanding balance of previously issued, unredeemed convertible bonds is 201 billion won. Including the new issuance, the total will increase to 221 billion won. The total number of shares convertible from both existing and new bonds is 87,263,288 shares, which is stated as 340.2% of the total 25,650,015 previously issued shares.

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.